D-0445-2023 Class II Terminated

Recalled by Denver Solutions, LLC DBA Leiters Health — Englewood, CO

FDA drug recall D-0445-2023 was initiated by Denver Solutions, LLC DBA Leiters Health on Feb 21, 2023 and is designated Class II. Reason for recall: CGMP DEVIATIONS The recall status is terminated (terminated Jan 11, 2024). Affected quantity: 8,136 units.

Recall details

Product Type
Drugs
Report Date
Mar 15, 2023
Initiation Date
Feb 21, 2023
Termination Date
Jan 11, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,136 units

Product description

Phenylephrine HCl 20 mg (80 mcg/mL) added to 0.9% Sodium Chloride 250 mL IV Bag, Rx only, Leiters Compounding Health 13796 Compark Blvd Englewood CO 80112, NDC 71449-148-94

Reason for recall

CGMP DEVIATIONS

Distribution pattern

Nationwide within the United States including VA or other Government facilities

Code information

Lot #: 2231026, Exp. Date 2/23/2023; 2231051, Exp. Date 3/11/2023; 2231156, Exp. Date 5/29/2023; 2231163, Exp. Date 3/26/2023; 223130, Exp. Date 4 5/7/2023; 2231308, Exp. Date 5/11/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0445-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0445-2023. Report a data issue: hello@regdatalab.com.